Perspectives from those who live it every day.
Each year, the American Cancer Society publishes data that gives a review of cancer statistics with foundational data that tells us about new cases in the U.S. and details on incidence and survival statistics state by state, overall and by cancer type. The latest report, which made headlines for a historic drop in cancer deaths, […]
Cancer death rates in the U.S. took the “biggest single-year drop ever,” according to a new report by the American Cancer Society. Improvements in the screening and treatment of lung cancer, the 2nd most common cancer and leading cancer killer, are a main contributor to this positive trend. Julie Brahmer, M.D., Director of the Kimmel […]
Numerous studies have shown that even a modest amount of weight loss can improve a variety of health-related metrics and quality of life for those who are overweight or obese. Attaining a healthy weight is important for breast cancer survivors, says new Kimmel Cancer Center breast cancer expert Jennifer Sheng, M.D. Studies have shown that […]
A new cancer test developed by Johns Hopkins Kimmel Cancer Center scientists screens for seven types of cancer in a completely unique way. DELFI is a new and different kind of cancer screening test. Rather than finding cancer gene mutations or chemical alterations to the DNA, known as epigenetic changes, it detects unique patterns in […]
Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances in treatment headed? Elizabeth Jaffee, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, describes explains in a 2018 interview on WYPR. http://www.wypr.org/post/why-pancreatic-cancer-so-deadly
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]
Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of HPV-related cancers. The panel was just one section of the Washington Post Cancer Summit. Viswanathan was joined by other experts in taking look at rising HPV-related cancer rates in the […]
Read the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more. From scientific meetings to our own dinner tables, conversations about better treatments for cancer are among the most frequently discussed health care topics. Everyone wants them—the doctors and scientists who […]
The team of cancer genetics experts that deciphered the genetic blueprints of cancer, have developed two new screening tests that have the promise to detect cancer in an early and curable stage. As the names of the tests indicate PapSEEK and UroSEEK, they seek out and find genetic evidence of cancer by detecting DNA released […]
Prostate cancer is a leading health problem for men. As strategies for prostate cancer screening and active surveillance are refined, men may benefit from early detection and cure of life-threatening prostate cancer but avoid overtreatment of the non-life-threatening variety. Read Kimmel Cancer Center director William Nelson’s editorial in Cancer Today, a publication of the American […]